文献速递角膜与眼表疾病

腺病毒介导人可溶性VEGF受体1经泪腺递送预防角膜新生血管

Prevention of Corneal Neovascularization by Adenovirus Encoding Human Vascular Endothelial Growth Factor Soluble Receptor (s-VEGFR1) in Lacrimal Gland.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

研究将编码人可溶性VEGF受体1(s-VEGFR1)的腺病毒载体注射至大鼠泪腺,评估其对碱烧伤诱导角膜新生血管(CNV)的预防效果及安全性。结果显示Ad-VEGFR1组12只中9只CNV被预防,优于Ad-Null组(3/10)和对照组(1/10),P=0.0317;泪液分泌及泪腺和三叉神经节中IL-1β、IL-6、TNF-α mRNA水平三组间无显著差异(P>0.05)。

要点

  • Ad-VEGFR1转染83%(10/12)大鼠泪腺,VEGFR1表达于泪腺腺泡细胞。
  • Ad-VEGFR1组12只中9只CNV被预防,显著优于Ad-Null(3/10)和对照(1/10)。
  • 泪液分泌及泪腺与三叉神经节炎性细胞因子mRNA三组间无显著差异。

核心结论

  • 腺病毒载体基因转移对泪腺结构和功能安全,泪腺局部表达人s-VEGFR1可在多数碱烧伤眼预防CNV。

研究设计与样本

  • 大鼠右眼泪腺注射AdVEGFR1载体(25 μL,1×10^10 pfu/mL),对照为AdNull载体(25 μL,1×10^10 pfu/mL)或25 μL生理盐水,随后以1 M NaOH行角膜碱烧伤。

主要发现

  • Ad-VEGFR1转染83%(10/12)大鼠,VEGFR1存在于泪腺腺泡细胞。
  • Ad-VEGFR1组12只中9只CNV被预防,Ad-Null组为3/10,对照组为1/10(P=0.0317)。
  • 三组泪液分泌及泪腺和三叉神经节中IL-1β、IL-6、TNF-α mRNA水平相似(P>0.05)。

关键数值与推荐

  • CNV预防比例:Ad-VEGFR1组9/12,Ad-Null组3/10,对照组1/10,P=0.0317。
  • 载体剂量:25 μL,1×10^10 pfu/mL;碱烧伤试剂:1 M NaOH。

临床怎么用

  • 泪腺可作为眼表抗VEGF基因治疗靶点,局部递送s-VEGFR1或可预防碱烧伤后CNV。

局限性

  • 研究为大鼠模型,样本量有限,长期安全性与临床转化需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aims of this study were (1) to determine the efficacy of adenovirus vector serotype 5 (Ad) encoding human soluble VEGF receptor 1 (s-VEGFR1) gene transfer to the lacrimal gland (LG); (2) to investigate whether expression of s-VEGFR1 prevents corneal neovascularization (CNV) induced by alkali burns; and (3) to evaluate the safety of the procedure. METHODS: AdVEGFR1 vectors (25 μL, 1 × 1010 pfu/mL) were injected in the right LGs of rats and were compared with AdNull vector (25 μL, 1 × 1010 pfu/mL) or 25 μL of saline (Control) before cornea alkali burns with 1 M NaOH. After 7 days, CNV was documented at the slit lamp. Tear secretion was measured with phenol red threads. The animals were tested for s-VEGFR1 mRNA and protein in the LG by quantitative (q)PCR and immunohistochemistry staining, respectively. qPCR was used to compare the mRNA levels of IL-1β, IL-6, and TNF-α in the LG and ipsilateral trigeminal ganglion (TG). RESULTS: Ad-VEGFR1 transfected 83% (10/12) of the rats. VEGFR1 was present in LG acinar cells. CNV was prevented in 9 of 12 animals in the Ad-VEGFR1 group, compared with the Ad-Null (3:10) and Control groups (1:10) (P = 0.0317). The tear secretion and cytokine mRNA levels in the LG and TG were similar in all three groups (P > 0.05). CONCLUSIONS: Adenoviral vector gene transfer was safe for LG structure and function. The LG as the target tissue showed local expression of human s-VEGFR1, and CNV was prevented in most of the eyes exposed to alkali burns.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Nominato LF, Dias AC, Dias LC, et al. Prevention of Corneal Neovascularization by Adenovirus Encoding Human Vascular Endothelial Growth Factor Soluble Receptor (s-VEGFR1) in Lacrimal Gland. Invest Ophthalmol Vis Sci. 2018. PMID: 30574658. doi:10.1167/iovs.17-22322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。